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The calcitonin (CT) gene is alternatively expressed in a tissue-specific fashion producing either the calcium 
regulatory hormone CT in the thyroid or the neuropeptide calcitonin gene related peptide (CGRP) in the 
brain. In medullary carcinoma of the thyroid both peptides are produced. We present here evidence for 
the existence in the human genome of a second CT gene, which is also expressed in human medullary thyroid 
carcinoma. This gene encodes a second human CGRP, differing from the known human CGRP in 3 of 
the 37 amino acids. 
Human calcitonin Calcitonin gene relatedpeptiak Medullary thyroid carcinoma 
Second human calcitonin gene Second human calcitonin gene relatedpeptide 
1. INTRODUCTION 
Studies of the rat calcitonin (CT) gene have 
revealed that this gene generates two distinct 
mRNAs by the selective use of alternative 
polyadenylation sites within the primary transcript 
[ 11. Thyroidal C-cells predominantly produce 
mRNA encoding the precursor of the calcium 
regulatory hormone calcitonin. This mRNA was 
shown to contain sequences transcribed from ex- 
ons 1 to 4 of the rat CT gene. In the brain, spinal 
cord, and cranial nerve ganglia mRNA encoding 
the precursor of the neuropeptide calcitonin gene 
related peptide (CGRP) is the product of CT gene 
expression. Exons l-3 of the rat CT gene are 
represented in both CT- and CGRP mRNA, 
whereas CGRP mRNA contains transcripts of ex- 
ons 5 and 6 instead of exon 4 as its 3 ‘-terminal 
part. 
Structural analysis of the human calcitonin 
(hCT) gene (fig.1) suggests that this gene, like the 
rat gene, may be alternatively expressed in a tissue- 
specific fashion. The first 4 exons specify the 
mature hCT mRNA [2], and a fifth exon encoding 
hCGRP has been identified [3]. Using exon 5 se- 
quences as probe, hCGRP mRNA has been 
detected in human medullary thyroid carcinoma 
(MTC), and precursor RNA species containing 
hCT- as well as hCGRP specific sequences were 
shown to be present in this tissue [3]. 
CGRP has been detected immunochemically in 
human thyroid, pituitary, and brain [4]. It has 
been isolated from human MTC tissue and 
characterized [5]. CGRP has been shown to have 
potent effects on the heart [a], and peripheral 
blood vessels as vasodilator [7]. 
To analyze the structure of hCGRP mRNA, and 
in particular the counterpart of rat exon 6 of the 
calcitonin gene, we screened a cDNA library of 
human MTC mRNA with a genomic hCGRP 
specific probe. The inserts of clones hybridizing to 
this probe were subjected to nucleotide sequence 
analysis. 
In addition to hCGRP cDNA a clonal insert was 
detected which predicts the existence of a second 
CT/CGRP gene in the human genome. 
2. MATERIALS AND METHODS 
2.1. cDNA library 
Total cellular RNA was isolated from a human 
MTC metastasis and poly(A)-rich RNA was ob- 
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tamed by oligo(dT)-cellulose chromatography. 
cDNA was synthesized using reverse transcriptase 
(Life Sciences) and oligo(dT)rz-1s as primer. ss- 
cDNA was converted to ds-cDNA using Klenow 
DNA polymerase. After Si-nuclease treatment, 
about 15 dC residues per 3 ‘-terminus were added 
using terminal transferase. The dC-tailed ds-cDNA 
was annealed to PstI linearized pBR322 with 
3’-terminal oligo(dG) tails. E. coli K12 1592 cells 
were transformed with the hybrid DNA and were 
grown on nitrocellulose filters on tetracycline con- 
taining agar plates. Replica filters were screened 
for colonies hybridizing to hCGRP specific probe 
labeled by nick translation. 
2.2. Nucleotide sequence analysis 
ds-DNA restriction enzyme fragments were la- 
beled 5 ’ -terminally using [Y-~~P]ATP and 
Td-polynucleotide kinase, or 3 ’ -terminally using 
[fu-32P]ddATP and terminal transferase. The 
fragments were digested with a second restriction 
endonuclease and were subsequently separated by 
5% polyacrylamide gel electrophoresis. Nucleotide 
sequences were determined according to the 
chemical modification technique 181. 
3. RESULTS 
A cDNA library derived from human MTC 
metastasis mRNA was screened with an hCGRP 
(exon 5) specific probe (BgZII-PvuII fragment, 
fig. 1). About one in 1000 cDNA clones hybridized 
to this probe. The inserts of two hybridizing 
clones, pCGRP-3 and pCGRP-4, with lengths of 
1100 and 800 nucleotides, respectively, were sub- 
jected to nucleotide sequence analysis. Fig.2 shows 
the restriction enzyme recognition sites relevant to 
this analysis. Total plasmid DNA was digested 
with either PstI, BgfiI, P&I, Sac1 or BstNI. The 
resulting fragments were 5 ‘- or 3 ‘-terminally la- 
beled and digested with one of the remaining 
restriction endonucleases. Fragments labeled at 
Fig. 1. Organization of the hCT gene. The 6 exons and 
some restriction enzyme recognition sites are indicated. 
Gene organization was determined partially by DNA 
sequencing and by electron-microscopic heteroduplex 
mapping of a 6.5 kb TuqI fragment with hCT and 
hCGRP cDNAs, respectively [2]. 
Fig.2. Restriction enzyme recognition sites within the 
inserts of plasmids pCCiRP-3 and pCGRP-4. Nucleotide 
sequences were determined starting from these 
recognition sites after 3 ‘- and 5 ‘-end labeling of the 
fragments and digestion with a second restriction 
endonuclease. The horizontal arrows indicate from 
which parts of the hCT gene the sequences derive 
(pCGRP-3) or to which parts of the hCT gene the 
sequences are related (pCGRP-4). 
one of their termini were isolated and their sequen- 
ces analyzed. 
The sequencing results show that the insert of 
pCGRP-3 is derived from the hCT gene, In addi- 
tion to the sequence of exon 5 [3), a sequence of 
432 nucleotides at the 3 ‘-end was determined. This 
sequence is 80% homologous to the corresponding 
3 ‘-terminal non-translated exon 6 derived se- 
quence in rat CGRP mRNA [ 11. The sequence con- 
tains the variant polyadenylation enzyme recogni- 
tion sequence ATTAAA (nucleotides 688-693 in 
fig.3), at the same position as in rat CGRP mRNA. 
On the basis of this homology, this sequence has 
been designated exon 6 in the hCT gene (fig.1). At 
- 
Fig.3. Comparison of the nucleotide sequence of the insert of pCGRP-4 to the sequence of exon 3 (derived from the 
hCT gene and hCT cDNA clones, fig.Z), and exons 5 + 6 (derived from the hCT gene and pCGRP-3). Gaps (indicated 
by -) have been introduced to maximize nucleotide sequence homology. The amino acids encoded by the hCT gene 
and substitutions encoded by pCGRP-4 are shown. The hCGRP sequence is in italics. The TGA stop codon and the 
presumed poly(A) addition enzyme recognition sequences are underlined. 
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asp tyr val gln met lys ala ser glu leu g1u gln glu gln glu 
25 
hCT gene 5'--- AG CAC TAT GTG CAG ATC AAG CCC ACT GAG CTG GAG CAG GAG CAA GAG 
pCGRP-4 5’--- A G 
lYS 
arg glu gly sex arg lie ile ala gin iys arg allo qs asp thr, ala 
50 
exon 3 +r-%n 5 . 75 CCRP 
AGA GAG CCC TCC AGA ATC ATT (XC CAG AAG AGA CCC TGT GAC ACT GCC 
. . . . . . . . . 
CC A c TC cc CA 
thr gin ser ser ser ala am 
thl* q,s ml thr hs az’g ILLI <:lu gly Iw lau v”cr my ser gly gly 
ID0 125 
ACC TGT GTG ACT CAT CGG CTG GCA GGC TTG CTG AGC AGA TCA GGG GGT 
C 
A G C 
met SEF 
gly al-g arg arg arg asp leu gin ala 
200 225 
CGC AGG CGC CGC AGG GAC CTT CAA GCC TGA GCA GCT ChA TGA CTCAAGA - 
. . 
A C G 
exon +I+ . 5 exon 6 250 
2i5 
AG---TCACAATAAI\GCTCAACTCCTCCTT-------TTMTGTCT~TG~CC~TTTGTAGGA 
. . . . . . , . . . . . . . . . . . . . . . . . . . . 
AAGTTC G A ACCATTTCCA T C GT GT AG C ET AG 
32.5 350 
AAGGCTCCATGGAAGACATACATATAGGCATCCTTCTTGATACTG~CTATCTT-CTTTCT 
. . . . . . . . . . . . . . . . . . . . 
T C C TC G TT -Ah- AAGCGCAC 
375 400 425 
---TTGAAAGGAACTATTGCTAAI\TGCAG~CMGCTCATTGCAGTTACCTATTGTGCATC-T 
. . . .*.. . . . . . . . . . . . 
CAC GAAA G AT A C -- TT GG A 
450 475 
TTTTAAATACTTCATTATGTAACCATAAATCTGACACCATC 
. . . . . . . . . . . . . . . . . . I. . 
T TTAATTC CCAGTA GTG- TG C A 
500 525 550 
. . . . . . . . . . . . . . . . . . 1 . . . . . . I 
CTGGTT TTTCG-GAG T G AT -- CA CA C T 
575 600 
ATGAAATCACTGCCTCTTG-GGCATCTGGGGACACATGGTA------ATGCTGTGCCTTGAC- 
. . . . . . . . . . . . . . 
G G T TC CA ATGGTG TTA 
625 650 675 
----AGAAGTA---------ATTTGTTTAAAGAN\TGTCA 
. . . . . . . . . . . . . . . . . . . . . . . . 
TCTA CATGATTGTATA GA AT CC TC 
ATCAAAATTAAAAATGTATTTTCTATACCCTT 3'-end insert pCGRP-3 
. . . . . . 725 
G GCA GGG AT GTTTCAAAACCTTGGTCATGCATTACMCTT 
750 775 800 
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GTTTTCTTATGTMTAATAATGATGATGATMTAAATTTTTGAGTGCTT 3'-end insert 
pCGRP-4 
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the 5 ’ -end of the insert of pCGRP-3, a sequence of 
466 nucleotides corresponding to the region of the 
intron between exons 4 and 5 (the entire sequence 
of which has been determined, unpublished) adja- 
cent to exon 5 was found. This probably indicates 
that the insert of pCGRP-3 is a product of reversed 
transcription of an incompletely processed hCGRP 
precursor RNA possessing a poly(A) tail. Such 
precursor molecules have been detected in large 
amounts in human MTC tissue 131. It has been 
shown that in mature hCGRP mRNA exon 5 se- 
quences are coupled to exon 3 sequences at their 
5’-end, as they are in rat CGRP mRNA. 
The insert of pCGRP-4 does not derive from the 
first hCT gene. Within this plasmid, a sequence 
92% homologous to exon 3 of the hCT gene, 
followed by a sequence 92% homologous to exon 
5 and a sequence 65% homologous to exon 6 were 
found (fig.3). At the 3’-end, a sequence of 91 
nucleotides found in neither pCGRP-3 nor rat ex- 
on 6 is present. Although the variant ATTAAA se- 
quence (nucleotides 688-693 in fig.3) is conserved, 
it is more likely that the usual AATAAA sequence 
at positions 784-789 serves as poly(A) addition en- 
zyme recognition site within this mRNA. 
4. DISCUSSION 
The sequencing results indicate that the human 
genome contains, in addition to the known hCT 
gene, a second distinctly different hCT gene, which 
is expressed in human MTC. Evidence for the ex- 
istence of a second hCT gene has already been ob- 
tained in hybridization studies of hCT gene 
specific probes with human DNA. In TaqI digested 
human DNA a 6.5 or 8.0 kb polymorphic restric- 
tion enzyme fragment reacts to a probe containing 
exons 2,3, and 4 of the hCT gene [lo]. In addition, 
2.3 and 3.0 kb bands were observed which could 
not be explained as fragments of the hCT gene. A 
probe containing only exon 4 (hCT-encoding) se- 
quences does not detect these extra bands. The ex- 
on 3-like part of pCGRP-4 @WI/Sac1 fragment, 
fig.2) hybridizes to the 2.3 and 3.0 kb TaqI 
fragments in human DNA digests, and also to the 
6.5/8.0 kb bands, as expected on the basis of its 
high degree of homology to the hCT gene exon 3. 
The exon 5 +6 part of pCGRP-3 hybridizes to the 
polymorphic 6.518-O kb laq1 fragments, and, 
more weakly, to a 2.6 kb TaqI fragment; the exon 
5 + 6-like part of pCGRP-4 (SacI/PstI fragment) 
hybridizes much stronger to the 2.6 kb TaqI frag- 
ment, and, more weakly, to the 6.5’8.0 kb Taqi 
fragments (fig.4). These 2.3, 2.6, and 3.0 TaqI 
fragments are not present within the inserts of both 
cosmid clones containing the hCT gene isolated by 
us [2]. This indicates that the second hCT gene is 
not located immediately adjacent to the hCT gene 
on chromosome 11 [lo]. The 2.3, 2.6, and 3.0 kb 
Z%qI fragments do not derive from an allele of the 
first hCT gene. In the DNA of all individuals 
screened for the 6518.0 kb TaqI restriction en- 
zyme recognition site polymorphism, the extra 
7’aqI fragments are detected, in addition to 
fragments of 8.0 kb, 6.5 kb, or both [lo]. 
It is noteworthy that, although this newly 
discovered gene shares a great deal of structural 
features with the hCT gene, a region homologous 
to the hCT encoding exon 4 seems to be absent. 
This is implicated by the absence of hybridizing 
TagI fragments other than the 6.5f8.0 kb 
fragments to the exon 4 specific probe. Never- 
theless, a second calcitonin has been reported to be 
produced in man [ 11,121. This calcitonin-like pep- 
tide is indistinguishable from synthetic salmon 
calcitonin-( l-32) (sCT) on high-performance li- 
quid chromatography. Since hCT and sCT are on- 
ly 50% homologous in their amino acid sequences, 
although sCT has a lo-times more potent 
a b kb 
Fig.4. Southern blot analysis of human TaqI digested 
DNA. (a) A probe containing hCT gene exons 2, 3, and 
4 detects an 8.0 kb fragment and hybridizes more weakily 
to 2.3 and 3.0 kb fragments. (b) A probe containing the 
exon 5 +6-like sequences of the second hCT gene 
hybridizes trongly to a 2.6 kb fragment and to the 
8.0 kb fragment, containing exons 2-6 of the first hCT 
gene. 
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hypocalcaemic effect in man than has hCT 1131, it 
is possible that the coding sequence for the sCT- 
like substance in man is insufficiently homologous 
to the hCT coding sequence to be detected with a 
hCT specific probe. The possibility that the second 
hCT gene contains the code for the sCT-like 
material should be borne in mind. 
The most intriguing aspect of this novel gene is 
the fact that it encodes a secnd hCGRP, differing 
from the known hCGRP in 3 of 37 amino acids 
(fig.3). Interestingly, 2 of these 3 differences occur 
at positions also modified in rat CGRP when com- 
pared to hCGRP, one of the modifications being 
the same (Asp vs Asn, residue 3). This probably in- 
dicates that these amino acid residues may be 
substituted by others without altering the 
biological activity of the peptide. The coding se- 
quences for pairs of basic amino acids flanking the 
hCGRP sequence, needed for excision of hCGRP 
from its precursor, the Gly-Arg-Arg-Arg sequence 
needed for C-terminal amidation of hCGRP and 
the TGA stop codon, followed by a second TGA 
in the same reading-frame, are all conserved in the 
second hCT gene. 
It is not unlikely that antibodies raised against 
hCGRP cross-react with the second hCGRP pep- 
tide specified by the second hCT gene. Im- 
munochemical data demonstrating the presence of 
hCGRP in different tissues should therefore be in- 
terpreted with caution in respect to conclusions 
concerning the expression of the hCT gene. 
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